相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Redirected tumor-specific allogeneic T cells for universal treatment of cancer
Assaf Marcus et al.
BLOOD (2011)
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
Renier J. Brentjens et al.
BLOOD (2011)
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
Paul F. Robbins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
TCRs Used in Cancer Gene Therapy Cross-React with MART-1/Melan-A Tumor Antigens via Distinct Mechanisms
Oleg Y. Borbulevych et al.
JOURNAL OF IMMUNOLOGY (2011)
In Vitro Comparison of Three Different Chimeric Receptor-modified Effector T-cell Populations for Leukemia Cell Therapy
Irene Pizzitola et al.
JOURNAL OF IMMUNOTHERAPY (2011)
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
Maria R. Parkhurst et al.
MOLECULAR THERAPY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
James N. Kochenderfer et al.
BLOOD (2010)
Building Better Chimeric Antigen Receptors for Adoptive T Cell Therapy
John S. Bridgeman et al.
CURRENT GENE THERAPY (2010)
Adoptive T cell therapy of cancer
Malcolm K. Brenner et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Enhancing adoptive immunotherapy of cancer
Jennifer A. Westwood et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Grafting chimeric antigen receptors to redirect T cells Carving the CAR
S. R. Riddell et al.
GENE THERAPY (2010)
Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc 'spacer' domain in the extracellular moiety of chimeric antigen receptors avoids 'off-target' activation and unintended initiation of an innate immune response
A. Hombach et al.
GENE THERAPY (2010)
Generation of multi-functional antigen-specific human T-cells by lentiviral TCR gene transfer
M. Perro et al.
GENE THERAPY (2010)
Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4
Scott Wilkie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Application of Adoptive T-Cell Therapy Using Tumor Antigen-Specific T-Cell Receptor Gene Transfer for the Treatment of Human Leukemia
Toshiki Ochi et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy
Anne-Marie Rasmussen et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Selected Murine Residues Endow Human TCR with Enhanced Tumor Recognition
Gil Bialer et al.
JOURNAL OF IMMUNOLOGY (2010)
Genetic redirection of T cells for cancer therapy
Jennifer A. Westwood et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Comparison of anti-CD3 and anti-CD28-coated beads with soluble anti-CD3 for expanding human T cells: Differing impact on CD8 T cell phenotype and responsiveness to restimulation
Yixin Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
Gavin M. Bendle et al.
NATURE MEDICINE (2010)
T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing
Coen Govers et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Safety and immunologic effects of IL-15 administration in nonhuman primates
Carolina Berger et al.
BLOOD (2009)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes
Patrick J. Hanley et al.
BLOOD (2009)
Lentiviral vectors encoding human MUC1-specific, MHC-unrestricted single-chain TCR and a fusion suicide gene: potential for universal and safe cancer immunotherapy
Xiaochuan Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008
Wolfgang Uckert et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Kinetic Preservation of Dual Specificity of Coprogrammed Minor Histocompatibility Antigen-Reactive Virus-Specific T Cells
Marleen M. van Loenen et al.
CANCER RESEARCH (2009)
Adoptive transfer of virus-specific and tumor-specific T cell immunity
Carolina Berger et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
The promise and potential pitfalls of chimeric antigen receptors
Michel Sadelain et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Making and circumventing tolerance to cancer
Thomas Kammertoens et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4(+) and CD8(+) T cells for use in the adoptive immunotherapy of cancer
K. Birkholz et al.
GENE THERAPY (2009)
IL-13 receptor-alpha 2: a novel target for cancer therapy
Bharat H. Joshi et al.
IMMUNOTHERAPY (2009)
Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain
Juergen Kuball et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
A Herceptin-Based Chimeric Antigen Receptor with Modified Signaling Domains Leads to Enhanced Survival of Transduced T Lymphocytes and Antitumor Activity
Yangbing Zhao et al.
JOURNAL OF IMMUNOLOGY (2009)
Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression
Nabil Ahmed et al.
MOLECULAR THERAPY (2009)
Genetic Manipulation of Tumor-specific Cytotoxic T Lymphocytes to Restore Responsiveness to IL-7
Juan F. Vera et al.
MOLECULAR THERAPY (2009)
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
Christian S. Hinrichs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Engineering lymphocyte subsets: tools, trials and tribulations
Carl H. June et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Redirecting specificity of T-cell Populations for CD19 using the Sleeping beauty system
Harjeet Singh et al.
CANCER RESEARCH (2008)
Retroviral transfer of a dominant TCR prevents surface expression of a large proportion of the endogenous TCR repertoire in human T cells
D. P. Hart et al.
GENE THERAPY (2008)
Relationship of p53 Overexpression on Cancers and Recognition by Anti-p53 T Cell Receptor-Transduced T Cells
Marc R. Theoret et al.
HUMAN GENE THERAPY (2008)
Adoptive transfer of effector CD8(+) T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Retargeting of human T cells to tumor-associated MUC1: The evolution of a chimeric antigen receptor
Scott Wilkie et al.
JOURNAL OF IMMUNOLOGY (2008)
Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-β receptor
Aaron E. Foster et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Sleeping beauty transposon-mediated engineering of human primary T cells for therapy of CD19(+) lymphoid malignancies
Xin Huang et al.
MOLECULAR THERAPY (2008)
Epstein-Barr virus sustains tumor killers
Richard J. O'Reilly
NATURE MEDICINE (2008)
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Martin A. Pule et al.
NATURE MEDICINE (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Targeting the Wilms tumor antigen 1 by TCR gene transfer:: TCR variants improve tetramer binding but not the function of gene modified human T cells
Sharyn Thomas et al.
JOURNAL OF IMMUNOLOGY (2007)
Gene-engineered varicella-zoster virus-reactive CD4+ cytotoxic T cells exert tumor-specific effector function
Silke Landmeier et al.
CANCER RESEARCH (2007)
Antitumor activity of dual-specific T cells and influenza virus
A. Murphy et al.
CANCER GENE THERAPY (2007)
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond
Cyrille J. Cohen et al.
CANCER RESEARCH (2007)
Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex
Mirjam H. M. Heemskerk et al.
BLOOD (2007)
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer
Michael H. Kershaw et al.
CLINICAL CANCER RESEARCH (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Addition of the CD28 signaling domain to chimeric T-cell receptors enhances chimeric T-cell resistance to T regulatory cells
A. Loskog et al.
LEUKEMIA (2006)
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability
Cyrille J. Cohen et al.
CANCER RESEARCH (2006)
Programming CD8(+) T cells for effective immunotherapy
Christian S. Hinrichs et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells
MA Pulè et al.
MOLECULAR THERAPY (2005)
The role of extracellular spacer regions in the optimal design of chimeric immune receptors - Evaluation of four different scFvs and antigens
RD Guest et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Exploiting T cell receptor genes for cancer immunotherapy
S Xue et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Human γδ T cells as mediators of chimaeric-receptor redirected anti-tumour immunity
M Rischer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy
C Rossig et al.
BLOOD (2002)
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR zeta/CD28 receptor
J Maher et al.
NATURE BIOTECHNOLOGY (2002)
分享论文
